Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne - 23 Mar 2010

Fernando Suran L, Broadfoot Andrew J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allopurinol
Share to Anticonvulsants
Share to Carbamazepine
Share to Cyclosporine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Hypersensitivity

Share to Gout Suppressants

Share to Immunization, Passive

Share to Stevens-Johnson Syndrome

Source

Open in PubMed Open full text

Identifiers

PMID: 19933789
DOI: 10.1503/cmaj.090401
PMCID: PMC2842859

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening.PMID 19933789Read ↗

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical ImplementationSemantic proximity Read ↗

Pharmacogenetic markers of severe cutaneous adverse drug reactions.Semantic proximity Read ↗

Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.Semantic proximity Read ↗

Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactionsSemantic proximity Read ↗

Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art.Semantic proximity Read ↗

[Pharmacogenomics in dermatology].Semantic proximity Read ↗

The Immunogenetics of Cutaneous Drug Reactions.Semantic proximity Read ↗

Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.Semantic proximity Read ↗

Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.Semantic proximity Read ↗

Severe cutaneous adverse reactions: impact of immunology, genetics, and pharmacology.Semantic proximity Read ↗

A Recent Update of Pharmacogenomics in Drug-induced Severe Skin ReactionsSemantic proximity Read ↗

Pharmacogenomics in dermatology: from susceptibility genes to personalized therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.